Cameco Corporation (CCJ): Price and Financial Metrics
GET POWR RATINGS... FREE!
CCJ POWR Grades
- Momentum is the dimension where CCJ ranks best; there it ranks ahead of 67.69% of US stocks.
- CCJ's strongest trending metric is Growth; it's been moving up over the last 177 days.
- CCJ ranks lowest in Value; there it ranks in the 6th percentile.
CCJ Stock Summary
- With a price/sales ratio of 8.54, CAMECO CORP has a higher such ratio than 87.41% of stocks in our set.
- With a year-over-year growth in debt of -31.71%, CAMECO CORP's debt growth rate surpasses merely 10.64% of about US stocks.
- Revenue growth over the past 12 months for CAMECO CORP comes in at -29.94%, a number that bests only 6.2% of the US stocks we're tracking.
- Stocks that are quantitatively similar to CCJ, based on their financial statements, market capitalization, and price volatility, are ERJ, AVNS, FTI, MTX, and OC.
- CCJ's SEC filings can be seen here. And to visit CAMECO CORP's official web site, go to www.cameco.com.
CCJ Price Target
For more insight on analysts targets of CCJ, see our CCJ price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $19.57 | Average Broker Recommendation | 1.56 (Moderate Buy) |
CCJ Stock Price Chart Interactive Chart >
CCJ Price/Volume Stats
| Current price | $27.97 | 52-week high | $32.49 |
| Prev. close | $27.51 | 52-week low | $18.03 |
| Day low | $27.60 | Volume | 5,718,472 |
| Day high | $28.43 | Avg. volume | 7,251,669 |
| 50-day MA | $26.74 | Dividend yield | 0.22% |
| 200-day MA | $24.66 | Market Cap | 11.14B |
Cameco Corporation (CCJ) Company Bio
Cameco Corporation produces and sells uranium worldwide. The company operates through Uranium, Fuel Services, and NUKEM segments. The company was founded in 1987 and is based in Saskatoon, Canada.
Latest CCJ News From Around the Web
Below are the latest news stories about CAMECO CORP that investors may wish to consider to help them evaluate CCJ as an investment opportunity.
Vertex Stock Flashes Buy Signal; Gene-Editing Play Leads 5 Resilient Stocks In Bear MarketVertex Pharmaceuicals flashed a buy signal last week on positive gene-editing news. It's one of several resilient stocks to watch in the bear market. |
7 Stocks That Could Explode After the 2022 Midterm ElectionsGiven that historical trends point to Republicans winning after the 2022 midterm elections, these are the stocks to watch. |
Cameco (CCJ) Stock Moves -0.67%: What You Should KnowIn the latest trading session, Cameco (CCJ) closed at $25.12, marking a -0.67% move from the previous day. |
Cameco (CCJ) Gains As Market Dips: What You Should KnowIn the latest trading session, Cameco (CCJ) closed at $28.40, marking a +0.35% move from the previous day. |
Baselode Intersects Best Drill Hole To Date With 0.90% U3O8 Over 31.0 Metres Starting at 69.3 m True Vertical DepthBaselode Energy Corp. (TSXV: FIND) (OTCQB: BSENF) ("Baselode" or the "Company") is pleased to announce the geochemical assay results from drill hole AK22-069 of 0.90% U3O8 over 31.0 m starting at 69.3 m true vertical depth which includes 1.86% U3O8 over 12.5 m at 79.7 m true vertical depth. AK22-069 is the latest and best hole to date from the now-complete 22,500 metre diamond drill program (the "Program") on the ACKIO high-grade uranium discovery ("ACKIO"), Hook project, Athabasca Basin area (t |
CCJ Price Returns
| 1-mo | -2.95% |
| 3-mo | 33.89% |
| 6-mo | -8.56% |
| 1-year | 28.36% |
| 3-year | 204.04% |
| 5-year | 205.93% |
| YTD | 28.24% |
| 2021 | 63.20% |
| 2020 | 51.46% |
| 2019 | -21.07% |
| 2018 | 23.59% |
| 2017 | -9.04% |
CCJ Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching CCJ
Want to do more research on Cameco Corp's stock and its price? Try the links below:Cameco Corp (CCJ) Stock Price | Nasdaq
Cameco Corp (CCJ) Stock Quote, History and News - Yahoo Finance
Cameco Corp (CCJ) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...